A premature infant on total parenteral nutrition (TPN) with IntralipidR (IL) developed hemolytic anemia with striking stomatocytosis, which cleared when IL was discontinued; 10-month hematologic follow-up has been normal. Another infant on IL also developed hemolytic anemia and stomatocytosis, but expired from complications of prematurity. Ten additional high risk infants on TPN with standard amounts of IL were studied. All Jcvcloped stomatocytosis. In 9 cases 25% to 50% of RBC's were affected. Stomatocytosis, absent before IL administration, appeared by day 4 -7 of IL, peaked at day 5-18. and disappeared 7-10 days after discontinuing IL. One of these infants developed severe hemolytic anemia. Routine transfusions obscured signs of hemolysis in the others. Three infants receiving TPN without IL showed no stomatocvtosis; 2 of these developed stomatocytosis when switched to IL.
Stomatocytosis is associated with severe abnormalities of RBC membrane composition and function and, occasionally, hemolysis. Also, fetal RBC membranes are different from those of adults. Our findings suggest: (1) IL or its metabolic byproducts interact with newborn RBC'S to induce a structural or functional membrane change and may increase susceptibility to hemolysis. (2) Infants on IL should be monitored for signs of hemolysis; (3) An experimental model for the study of membrane physiology is suggested. Marked poikilocytosis accompanied by membrane fragmentation and microspherocyte formation have been described in occasional cases of hereditary elliptocytosis. We have studied a healthy 10 year old black male with a compensated hemolytic anemia, elliptocytosis and severe red cell fragmentation. Several parameters known to affect RBC membrane stability were found to be normal: pyruvate kinase activity, RBC ATP content, unstable hemoglobin evaluation, direct and indirect Coomb's tests, membrane thermal sensitivity, RBC calcium and calcium permeability, RBC cholesterol and phospholipid content, and the distribution of membrane phosphatides including phosphatidyl ethanolamine. The only abnormality found was a RBC GSH content approximately 50% of normal (below that seen in most G-6-PD deficiencies). Furthermore, in centrifugally-separated cells, GSH content decreased progressively with increasing cell density. Unlike G-6-PD deficiency the low GSH content was not accompanied by abnormal oxidant sensitivity; GSH was not diminished by incubation with ascorbate-aminotriazole and no methemoglobin or sulfhemoglobin was formed. Enzymes involved in GSH metabolism (GSH reductase, G-6-PD, GSH peroxidase) were slightly elevated. Incubation of RBC with ~~-~l u tamate, with subsequent molecular weight separation of the GSH inermediates, suggests an intact GSH synthetic pathway but diminished glutama am ate content. The low RBC GSH may be related to the RBC morphologic features and hemolysis. Children with sickle cell disease have a markedly increased susceptibility to pneumococcal septicemia and meningitis, attributed primarily to the loss of splenic function. Review of 24 cases of pneumococcal meningitis in sickle cell patients revealed a high frequency of recurrence chiefly among those infants whose initial episode of pneumococcal meningitis occurred before the age of 15 months. Twelve of 24 patients (50%) were under the age of 15 months; eight (33%) were below the age of 12 months (5,6, 6f,8,9,11,12, and 12 months) at the time of initial episode of meningitis. Five (20%) of 24 patients developed recurrent pneumococcal meningitis; four patients had omrecurrence and one had three recurrences. All recurrences were seen in infants who were below the.age of 15 months at the time of initial episode of meningitis. The interval between the initial episode and the recurrence ranged between one and 24 months. Evaluation of blood smear at the time of initial diagnosis of meningitis in 3/4 patients with recurrence revealed the presence of Howell-Jolly bodies (5,9, and 15 months)indicating splenic hypofunction. In this study pneumococcal meningitis in sickle cell patients occurr ed earlier than is generally reported and the recurrence rate was high when the initial episode was at less than 15 months, suggesting a defect in host defense in addition to the absence of splenic function in these very young patients. This suggests the ieed to evaluate antibody forming capacity in such infants. Transfusion of uncrossmatched blood is only done in an emergency situation because of the risk of transfusion reaction. We reviewed the records of 65 patients who received uncrossmatched blood between 1969 and 1976. Emphasis was placed on the presence of major transfusion reactions. Forty six of these patients received group specific blood. Of the 19 patients that received non type specific blood 15 were transfused with.O-blood, two with 0+ and 2 others with B-. In one patient receiving non type specific blood the crossmatch was found to be incompatible after the blood had been given. Eighteen patients had been previously transfused and 3 0 received subsequent transfusions. No documented transfusion reaction occurred in any of the 65 patients. F're-existing shock and bleeding diathesis made this evaluation difficult in some cases. Eight patients died within 24 hours of receiving their uncrossmatched blood, none with evidence of transfusion reaction. In life threatening situations when time will not permit compatability testing. uncrossmatched 0-or type specific blood should be used because the risk of a major transfusion reaction is minimal.
